Ohlbe
★★★

France,
2020-04-28 23:01
(142 d 16:54 ago)

Posting: # 21358
Views: 2,421
 

 FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe
Activity
 Admin contact
21,068 posts in 4,392 threads, 1,463 registered users;
online 17 (0 registered, 17 guests [including 11 identified bots]).
Forum time: Friday 15:56 CEST (Europe/Vienna)

The great enemy of the truth is very often not the lie–
deliberate, contrived and dishonest—but the myth—
persistent, persuasive and unrealistic.    John F. Kennedy

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5